BioSpace News Archive

Pure-Vu® System launched in high value U.S. inpatient colonoscopy market with first commercial placements at early adopter hospitals completed in early-October

Bicycle Therapeutics plc announced that management will present at the Jefferies 2019 London Healthcare Conference on Wednesday, November 20, 2019 at 2:40 p.m. GMT in London, England.

Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer’s, ALS and Parkinson’s disease

Rubius Therapeutics, Inc. reported third quarter 2019 financial results and provided an overview of operational progress.

Ultromics, the UK-based health technology firm at the forefront of applying artificial intelligence to echocardiography, has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its image analysis system, EchoGo Core.

The Urology Care Foundation, the world’s leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce Irv Rothman has joined the Foundation Board of Directors

This third quarter of 2019 saw us move steadily towards full recruitment of the NefIgArd study, despite a somewhat slower pace during the summer months.

Athersys, Inc. announced that its collaborator in Japan, HEALIOS K.K. received notification this week from the Pharmaceutical Affairs and Food Sanitation Council that its acute respiratory distress syndrome clinical program using HLCM051, will receive the orphan regenerative medicine designation from the Ministry of Health, Labour and Welfare within the next few weeks.

Digirad Corporation reported its financial results for the third quarter and nine months ended September 30, 2019.

Adynxx, Inc. announced financial results and provided a business update for the quarter ended September 30, 2019.